Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CD19 CAR-T Cells in R/R B-NHL
NCT06698484Phase 2Recruiting
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Jun 2021
- Primary completion
- Jun 2025
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CD19 CAR-T cells in B-cell non-Hodgkin lymphoma, sponsored by Universiti Kebangsaan Malaysia. Started Jun 2021; status: recruiting.
02
Drugs
CD19 CAR-T cells
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT06698484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06698484.